Opportunities for the use of fatty acids of erythrocytes membranes and blood serum for diagnosis of Crown's disease

Aim of work is to study the features of the fatty acid (FA) composition of the membranes of erythrocytes (Er) and blood serum (BS) in patients with Crohn’s disease (CD) for possible use for diff erential diagnosis.

Materials and methods. Using a gas chromatography-mass spectrometric system (GC/MS) based on three Agilent 7000B quadrupoles (USA), the composition of erythrocytes (Er) and blood serum (SC) of 60 people was studied: 19 — with Crohn’s disease (CD, 34±6,2 years), 21 — with unclassifi ed colitis (UCC, 35,2±4,7 years) and 20 healthy individuals (32,9±5,7 years).

Results. It was found that the levels of most saturated, monounsaturated omega-9, omega-6 PUFAs were signifi cantly higher, and the content of the predominant part of omega-3, a number of omega-6 (linoleic, eicosadienoic, arachidonic) was lower than in healthy individuals. The relative content of FA in patients with unclassifi ed colitis turned out to be intermediate between those in patients with CD and healthy (p <0,0001–0,02). The obtained diff erentiating values of FA levels and their indices in the erythrocyte membranes made it possible to identify patients with suspected Crohn’s disease from those who were diagnosed with unclassifi ed colitis, which indicates the high potential of this approach for diff erential diagnosis.

Conclusion. The created diagnostic panels (FA of blood serum and erythrocyte membranes) made it possible to diff erentiate patients with CD from healthy individuals with fairly high levels of sensitivity and specifi city. The revealed features of the levels of FA membranes of Er and BS, as well as their ratio in patients with CD, are promising for the purposes of diff erential diagnosis, including in cases of unclassifi ed colitis.

1. Sands B. E., Siegel C. A. Crohn’s disease. In: Feldman M., Friedman L. S, Brandt L. J., eds. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier. 2010. chap 111.

2. Burisch J., Munkholm P. Infl ammatory bowel disease epidemiology. Curr. Opin. Gastroenterol. 2013, Vol. 29, No. 4, pp. 357–362.

3. Abraham C., Cho J. H. Inflammatory bowel disease. N. Engl. J. Med. 2009, Vol. 361, pp. 2066–2078.

4. Harris M. L., Bayless T. M. Dietary antigens as aggravating factors in Crohn’s disease. Dig. Dis. Sci. 1989, Vol. 34, pp. 1613–1614.

5. Sartor R. B. Pathogenesis and immune mechanisms of chronic inf lammatory bowel diseases. Am. J. Gastroenterol. 1997, Vol. 92, pp. 5S-11S.

6. Powell J. J., Harvey R. S., Ashwood P, Wolsten-croft R., Gershwin M. E., Thompson R. P. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J. Autoimmun. 2000, Vol. 14, pp. 99–105.

7. Uchiyama K., Odahara S., Nakamura M., et al. The fatty acid profile of the erythrocyte membrane in initial-onset inflammatory bowel disease patients. Dig. Dis. Sci. 2013, Vol. 58, pp. 1235–1243.

8. Kruchinina M. V., Azgaldyan A. V., Svetlova I. O., Shashkov M. V., Sokolova A. S., Kruchinin V. N. Features of the composition of fatty acids in blood serum and erythrocyte membranes in patients with inflammatory bowel diseases (pilot study). Modern problems of science and education. 2019, No. 3. DOI: 10.17513/spno.28868.

9. Friedman A. N., Yu Z., Tabbey R., Denski C., et al. Low blood levels of long-chain n-3 polyunsaturated fatty acids in US hemodialysis patients: clinical implications. Am. J. Nephrol. 2012, Vol. 36, pp. 451–458.

10. Arab L., Akbar J. Biomarkers and the measurement of fatty acids. Public Health Nutr. 2002, Vol. 5, pp. 865–871.

11. Kruchinina M. V., Kruchinin V. N., Prudnikova Ya. I. et al. Study of the level of fatty acids in erythrocyte membranes and serum of patients with colorectal cancer in Novosibirsk. Uspekhi molekulyarnoy onkologii = Advances in Molecular Oncology 2018;5(2):50–61.

12. Stillwell W. An introduction to biological membranes. Composition, structure and function. Second edition – UK London: Elsevier. 2016. 432 p.

13. Veglia F., Tyurin V. A., Blasi M., De Leo A., et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019. Vol. 569, No. 7754, pp. 73–78.

14. Hodson L., Skeaff C. M., Fielding B. A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid. Res. 2008, Vol. 47, pp. 348–380.

15. Asciutti-Moura L. S., Guilland J. C., Fuchs F., Richard D., Klepping J. Fatty acid composition of serum lipids and its relation to diet in an elderly institutionalized population. Am. J. Clin. Nutr. 1988. Vol. 48, pp. 980–987.

16. Sharon P., Stenson W. F. Enhanced synthesis of leukotriene B4 by colonic mucosa in infl am-matory bowel disease. Gastroenterology. 1984, Vol. 86, pp. 453–460.

17. Hommes D. W., Meenan J., de Haas M., et al. Soluble Fc gamma receptor III (CD16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. Gut. 1996, Vol. 38, pp. 564–567.

18. Tjonneland A., Overvad K., Bergmann M. M., Nagel G., et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut. 2009, Vol. 58, pp. 1606–1611.

19. Seimon T. A., Nadolski M. J., Liao X., Magallon J., et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-

20. dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. 2010, Vol. 12, pp. 467–482.

21. Saraswathi V., Hasty A. H. Inhibition of long-chain acyl coenzyme A synthetases during fatty acid loading induces lipotoxicity in macrophages. Arterioscler. Thromb. Vasc. Biol. 2009, Vol. 29, pp. 1937–1943.

22. Fritz V., Benfodda Z., Rodier G., Henriquet C., et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol. Cancer Ther. 2010, Vol. 9, pp. 1740–54.

23. Igarashi O., Sugano M., Ikeda I. A Modern Viewpoint of the Fatty Acid Nutrition Tokyo: Koseikan. 1998. 563 p.

24. Okuyama H., Kobayashi T., Watanabe S. Dietary fatty acids – The n-6/n-3 balance and chronic elderly disease. Prog. Lipid Res. 1997. Vol. 35, pp. 409–457.

25. Saku N., Kobayashi J., Kitamura S. Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages activated by silica. Prostaglandins Leukot. Essent. Fatty Acids. 1999. Vol. 61, pp. 51–54.

26. Li Q., Zhang Q., Wang M., Zhao S., Xu G., Li J. n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. Molecular Immunology, 2008, Vol. 45, pp. 1356–1365.

27. Lans W. E. M. Fish and Human Health – New York: NY Academic Press, 1986. 458 p.

28. Zholudev A., Zurakowski D., Young W., Leichtner A., Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am. J. Gastroenterol. 2004, Vol. 99, pp. 2235–2241.